How Does Ekra Affect Clinical Diagnostic Labs

The Eliminating Kickbacks in Recovery Act (EKRA) was signed into law in October 2018 as part of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. This legislation was designed to combat the opioid epidemic by addressing illegal kickbacks and patient brokering in the healthcare industry. While EKRA primarily focuses on substance abuse treatment facilities, it also has implications for clinical Diagnostic Labs. In this article, we will explore how EKRA affects clinical Diagnostic Labs and what steps labs can take to ensure compliance with this law.

What is EKRA?

Before diving into how EKRA affects clinical Diagnostic Labs, it is important to understand what this legislation entails. EKRA prohibits the payment or receipt of kickbacks in exchange for patient referrals to recovery homes, clinical treatment facilities, or laboratories. It applies to all Healthcare Providers, including clinical Diagnostic Labs, and carries significant penalties for violations.

How Does EKRA Affect Clinical Diagnostic Labs?

While EKRA primarily targets substance abuse treatment facilities, clinical Diagnostic Labs can also be impacted by this legislation. Here are some of the ways in which EKRA affects labs:

1. Prohibition of Kickbacks

1. Under EKRA, clinical Diagnostic Labs are prohibited from offering or accepting kickbacks in exchange for patient referrals.
2. This means that labs cannot provide any form of compensation to Healthcare Providers in exchange for sending patients their way.

2. Increased Scrutiny

1. With the enactment of EKRA, clinical Diagnostic Labs are facing increased scrutiny regarding their financial relationships with Healthcare Providers.
2. Labs must ensure that any arrangements they have in place with referring providers comply with EKRA and other anti-kickback laws.

3. Compliance Requirements

1. To comply with EKRA, clinical Diagnostic Labs need to have robust compliance programs in place.
2. These programs should include policies and procedures for preventing kickbacks and monitoring financial relationships with referring providers.

Penalties for Non-Compliance

It is crucial for clinical Diagnostic Labs to understand the potential consequences of non-compliance with EKRA. Violations of this law can result in severe penalties, including fines and imprisonment. Labs found to be in violation of EKRA may also face exclusion from federal healthcare programs, such as Medicare and Medicaid.

Steps for Ensuring Compliance

To ensure compliance with EKRA, clinical Diagnostic Labs can take the following steps:

1. Review and Update Policies

1. Labs should review their existing policies and procedures to ensure they align with the requirements of EKRA.
2. If necessary, policies should be updated to reflect the prohibition on kickbacks and the importance of compliance with anti-kickback laws.

2. Training and Education

1. Lab staff, especially those involved in sales and marketing, should receive training on EKRA and other relevant laws and Regulations.
2. Education sessions can help employees understand their obligations under EKRA and how to comply with the law in their day-to-day activities.

3. Monitoring Arrangements

1. Clinical Diagnostic Labs should closely monitor their financial relationships with referring providers to ensure compliance with EKRA.
2. Any arrangements that could potentially be construed as kickbacks should be reviewed and adjusted as needed to avoid violations of the law.

Conclusion

As EKRA continues to be enforced, clinical Diagnostic Labs must take proactive steps to ensure compliance with this legislation. By understanding the implications of EKRA and implementing robust compliance programs, labs can mitigate the risk of facing penalties for violations of this law. Ultimately, prioritizing compliance with EKRA not only protects labs from legal consequences but also upholds the integrity of the healthcare system as a whole.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on phlebotomy practices and healthcare. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.